Training program for cancer research related to infections in Mali
Infection-Associated Cancer Research Training Program in Mali
This study is all about helping researchers in Mali learn how to better understand and tackle cancers linked to infections, like cervical and liver cancer, so they can improve how these diseases are detected and treated for everyone in the community.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Northwestern University at Chicago NIH-funded |
| Lab location | 1 site (Chicago, United States) |
| Project ID | NIH-10916189 on NIH RePORTER |
What this research studies
This program focuses on training researchers in Mali to study infection-associated cancers, such as cervical, liver, gastric, and lung cancers, which are prevalent in the region. It aims to enhance skills in population-based cancer epidemiology and molecular studies, helping to identify specific risk factors and biomarkers. By building local research capacity, the program seeks to improve cancer detection, treatment, and patient outcomes in Mali. Participants will engage in collaborative research efforts that leverage existing expertise and resources.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals in Mali who are at risk for infection-associated cancers, particularly those with underlying infections.
Not a fit: Patients outside of Mali or those not at risk for infection-associated cancers may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to better detection and treatment strategies for infection-associated cancers in Mali, ultimately improving patient outcomes.
How similar studies have performed: Other research initiatives have successfully built local capacity for cancer research in similar contexts, indicating potential for success in this program.
Where this research is happening
Chicago, United States
- Northwestern University at Chicago — Chicago, United States (Active)
Researchers
- Principal investigator: Hou, Lifang — Northwestern University at Chicago
- Study coordinator: Hou, Lifang
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.